← Back to headlines
Pfizer Q1 2026 Earnings Beat Estimates Driven by Newer Drugs
Pfizer reported its first-quarter 2026 earnings, which surpassed analyst estimates. The pharmaceutical giant attributed the strong performance to the growth of its newer drug portfolio.
5 May, 12:45 — 5 May, 12:45
Sources
Showing 1 of 1 sources
Related Stories
US-Canada Trade Tensions Drive Up Prices and Spark Canadian Boycotts
17m ago
DMG Blockchain Solutions Reports Third-Quarter Financial Results
48m ago
SoftBank in Talks to Buy Majority Stake in Humanoid Robotics Startup 1X
48m ago
Raymond James Financial Announces Quarterly Dividend of $0.54 Per Share
1h ago